Affiliations: Inst. of Food Science and Technology, CNR, Via Roma 52 A/C, 83100, Avellino, Italy
References: (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective, , American Institute for Cancer Researc
Stavric, B., (1994) Clin. Biochem., 27, pp. 319-332
Middleton, E.J., Kandaswami, C., (1993) In: The Flavonoids: Advance Research since 1986, pp. 619-652. , (Hairbone, J.H. and Liss, A.R., Eds.), New York
Kuo, S.M., (1997) Crit. Rev. Oncog., 8, pp. 47-69
Garcia-Closas, R., Gonzalez, C.A., Agudo, A., Riboli, E., (1999) Cancer Causes Contr., 10, pp. 71-75
Cook, N.C., Samman, S., (1996) Nutr. Biochem., 7, pp. 66-76
Goldberg, D.M., Tsang, E., Karumanchiri, A., Diamandis, E.P., Soleas, G., Ng, E., (1996) Anal. Chem., 68, pp. 1688-1694
Avila, M.A., Velasco, J.A., Cansado, J., Notario, V., (1994) Cancer Res., 54, pp. 2424-2428
Ferrandina, G., Almadori, G., Maggiano, N., Lanza, P., Ferlini, C., Cattani, P., Piantelli, M., Ranelletti, F.O., (1998) Int. J. Cancer, 77, pp. 747-754
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., Hess, R.D., (1996) Oncogene, 13, pp. 1605-1614
Ranelletti, F.O., Ricci, R., Maggiano, N., Capelli, A., Scambia, G., Benedetti-Panici, P., Mancuso, S., Piantelli, M., (1992) Int. J. Cancer, 50, pp. 486-492
Yoshida, M., Yamamoto, M., Nikaido, T., (1992) Cancer Res., 52, pp. 6676-6681
Wei, Y.Q., Zhao, X., Kariya, Y., Fukata, H., Teshigawara, K., Uchida, A., (1994) Cancer Res., 54, pp. 4952-4957
Iwao, K., Tsukamoto, I., (1999) Biochim. Biophys. Acta, 1427, pp. 112-120
Larocca, L.M., Ranelletti, F.O., Maggiano, N., Rutella, S., La Barbera, E.O., Rumi, C., Serra, F., Leone, G., (1997) Int. J. Cancer, 73, pp. 75-83
Csokay, B., Prajda, N., Weber, G., Olah, E., (1997) Life Sci., 60, pp. 2157-2163
Hagiwara, M., Inoue, S., Tanaka, T., Nunoki, K., Ito, M., Hidaka, H., (1988) Biochem. Pharmacol., 37, pp. 2987-2992
Ferriola, P.C., Cody, V., Middleton, E., (1989) Biochem. Pharmacol., 38, pp. 1617-1624
Deschner, E.E., (1992) In: Phenolic Compounds in Food and Their Effects on Health II, 507, pp. 265-268. , (Huang, M.T., Ho, C.T. and Lee, C.Y., Eds.), American Chemical Society, Washington, DC
Barotto, N.N., Lopez, C.B., Eynard, A.R., Fernandez Zapico, M.E., Valentich, M.A., (1998) Cancer Lett., 129, pp. 1-6
Yokoo, T., Kitamura, M., (1997) Am. J. Physiol., 273, pp. 206-F212
Nagata, S., (1997) Cell, 88, pp. 355-365
Ashkenazi, A., Dixit, V.M., (1998) Science, 281, pp. 1305-1308
Krammer, P.H., Galle, P.R., Moller, P., Debatin, K.M., (1998) In: Advances in Cancer Research, 65, pp. 251-272. , (Vande Woude, G.F. and Klein, G., Eds.), Academic Press, Inc., San Diego
Kuida, K., Zheng, T.S., Na, S., Kuan, C.Y., Yang, D., Karasuyama, H., Rakic, P., Flavell, R.A., (1996) Nature, 384, pp. 368-372
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K., Peter, M.E., (1998) EMBO J., 17, pp. 1675-1687
Ferry, D.R., Smith, A., Malkhandi, J., Fyfe, D.W., De Takatas, P.G., Anderson, D., Baker, J., Kerr, D.J., (1996) Clin. Cancer Res., 2, pp. 659-668
Middleton, E. J., Kandaswami, C., (1993) In: The Flavonoids: Advance Research since 1986, pp. 619-652. , (Hairbone, J. H. and Liss, A. R., Eds.), New York
Kuo, S. M., (1997) Crit. Rev. Oncog., 8, pp. 47-69
Cook, N. C., Samman, S., (1996) Nutr. Biochem., 7, pp. 66-76
Goldberg, D. M., Tsang, E., Karumanchiri, A., Diamandis, E. P., Soleas, G., Ng, E., (1996) Anal. Chem., 68, pp. 1688-1694
Avila, M. A., Velasco, J. A., Cansado, J., Notario, V., (1994) Cancer Res., 54, pp. 2424-2428
Ranelletti, F. O., Ricci, R., Maggiano, N., Capelli, A., Scambia, G., Benedetti-Panici, P., Mancuso, S., Piantelli, M., (1992) Int. J. Cancer, 50, pp. 486-492
Wei, Y. Q., Zhao, X., Kariya, Y., Fukata, H., Teshigawara, K., Uchida, A., (1994) Cancer Res., 54, pp. 4952-4957
Larocca, L. M., Ranelletti, F. O., Maggiano, N., Rutella, S., La Barbera, E. O., Rumi, C., Serra, F., Leone, G., (1997) Int. J. Cancer, 73, pp. 75-83
Ferriola, P. C., Cody, V., Middleton, E., (1989) Biochem. Pharmacol., 38, pp. 1617-1624
Deschner, E. E., (1992) In: Phenolic Compounds in Food and Their Effects on Health II, 507, pp. 265-268. , (Huang, M. T., Ho, C. T. and Lee, C. Y., Eds.), American Chemical Society, Washington, DC
Barotto, N. N., Lopez, C. B., Eynard, A. R., Fernandez Zapico, M. E., Valentich, M. A., (1998) Cancer Lett., 129, pp. 1-6
Krammer, P. H., Galle, P. R., Moller, P., Debatin, K. M., (1998) In: Advances in Cancer Research, 65, pp. 251-272. , (Vande Woude, G. F. and Klein, G., Eds.), Academic Press, Inc., San Diego
Varadhachary, A. S., Salgame, P., (1998) Oncogene, 17, pp. 3271-3276
Korchak, H. L., Rich, A. N., Wilkenfeld, C., Rutherford, L. E., Weissmann, G., (1982) Biochem. Biophys. Res. Commun., 108, pp. 1495-1501
Watson, R. W. G., O'Neill, A., Brannigen, A. E., Coffey, R., Marshall, J. C., Brady, H. R., Fitzpatrick, J. M., (1999) FEBS Lett., 453, pp. 67-71
Jacobson, M. D., (1996) Trends Biochem. Sci., 21, pp. 83-86
Clement, M. V., Stamenkovic, I., (1996) EMBO J., 15, pp. 216-225
Clement, B. -V., Hirpara, J. L., Chawdhury, S. -H., Pervaiz, S., (1998) Blood, 92, pp. 996-1002
Buttke, T. M., Sandstrom, P. A., (1994) Immunol. Today, 15, pp. 7-10
Green, D. R., Reed, J. C., (1998) Science, 281, pp. 1309-1312
Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., Gougeon, M. L., (1995) J. Cell Biol., 130, pp. 157-167
Santos, A. C., Uyemura, S. A., Lopes, J. L., Bazon, J. N., Mingatto, F. E., Curti, C., (1998) Free Radic. Biol. Med., 24, pp. 1455-1461
Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., De Takatas, P. G., Anderson, D., Baker, J., Kerr, D. J., (1996) Clin. Cancer Res., 2, pp. 659-668
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line
Several malignant cell lines are resistant to CD95(Apo1/Fas)-mediated apoptosis, even when the CD95 receptor is highly expressed. Sensitivity to CD95-induced apoptosis can be restored using different molecules. In this study, we showed that quercetin, a naturally occurring flavonoid, in association with the agonistic anti-CD95 monoclonal antibody, increases DNA fragmentation and caspase-3 activity in HPB-ALL cells. These cells have been selected for their known resistance to CD95-induced apoptosis. At molecular level, quercetin lowers the level of intracellular reactive oxygen species, reduces mitochondrial transmembrane potential, thereby leaving the expression of CD95 receptor unchanged. Copyright (C) 1999 Federation of European Biochemical Societies.
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote